These findings may be the reason why CD28 on CD39+ secreting CD4 regulatory T cell is a risk factor for SS, whereas CD3 on CD39+ CD8+ T cell plays a protective role in SS. This evidence concerns the gene ENTPD1 and synovial sarcoma.